TR199901622T2 - Paroksetin terkipleri. - Google Patents

Paroksetin terkipleri.

Info

Publication number
TR199901622T2
TR199901622T2 TR1999/01622T TR9901622T TR199901622T2 TR 199901622 T2 TR199901622 T2 TR 199901622T2 TR 1999/01622 T TR1999/01622 T TR 1999/01622T TR 9901622 T TR9901622 T TR 9901622T TR 199901622 T2 TR199901622 T2 TR 199901622T2
Authority
TR
Turkey
Prior art keywords
paroxetine hydrochloride
paroxetine
paroxetine compositions
compositions
anhydrate
Prior art date
Application number
TR1999/01622T
Other languages
English (en)
Turkish (tr)
Inventor
Witold Jacewicz Victor
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR199901622T2 publication Critical patent/TR199901622T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/01622T 1997-01-15 1998-01-12 Paroksetin terkipleri. TR199901622T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound

Publications (1)

Publication Number Publication Date
TR199901622T2 true TR199901622T2 (xx) 1999-09-21

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01622T TR199901622T2 (xx) 1997-01-15 1998-01-12 Paroksetin terkipleri.

Country Status (21)

Country Link
US (1) US20010049442A1 (hu)
EP (1) EP0952831A1 (hu)
JP (1) JP2001508460A (hu)
KR (1) KR20000070151A (hu)
CN (1) CN1249686A (hu)
AP (1) AP9901604A0 (hu)
AU (1) AU730532B2 (hu)
BG (1) BG103648A (hu)
BR (1) BR9806754A (hu)
CA (1) CA2277480A1 (hu)
EA (1) EA002034B1 (hu)
HU (1) HUP0000960A3 (hu)
ID (1) ID23250A (hu)
IL (1) IL130856A (hu)
NO (1) NO993460L (hu)
NZ (1) NZ336587A (hu)
OA (1) OA11077A (hu)
PL (1) PL334568A1 (hu)
SK (1) SK95099A3 (hu)
TR (1) TR199901622T2 (hu)
WO (1) WO1998031365A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
TR200100444T2 (tr) * 1998-08-07 2001-07-23 Smithkline Beecham P.L.C. Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
JP4854115B2 (ja) 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
PT1109806E (pt) 1999-07-01 2004-02-27 Italfarmaco Spa Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CA2277480A1 (en) 1998-07-23
EP0952831A1 (en) 1999-11-03
PL334568A1 (en) 2000-03-13
SK95099A3 (en) 2000-01-18
WO1998031365A1 (en) 1998-07-23
JP2001508460A (ja) 2001-06-26
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
AP9901604A0 (en) 1999-09-30
HUP0000960A2 (hu) 2001-02-28
AU5567398A (en) 1998-08-07
OA11077A (en) 2003-03-13
US20010049442A1 (en) 2001-12-06
BG103648A (en) 2000-04-28
KR20000070151A (ko) 2000-11-25
NO993460D0 (no) 1999-07-14
IL130856A (en) 2001-09-13
HUP0000960A3 (en) 2001-04-28
BR9806754A (pt) 2000-03-14
EA199900655A1 (ru) 2000-02-28
ID23250A (id) 2000-03-30
AU730532B2 (en) 2001-03-08
NZ336587A (en) 2001-01-26
EA002034B1 (ru) 2001-12-24
IL130856A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
TR199901622T2 (xx) Paroksetin terkipleri.
DE69620443T2 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
DK1392714T3 (da) Steroider som agonister for FXR
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
CA2422374A1 (en) Purine derivatives
EA200201291A1 (ru) Производные пурина
EA200101203A1 (ru) Производные пурина
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
DK1268445T3 (da) 4-amino-5-cyano-2-anilinopyrimidinderivater og deres anvendelse som inhibitorer af cellecykluskinaser
DE60121461D1 (de) Kondensierte pyridoindolderivate
TR200101286T2 (tr) Eritromisin'in yeni türevleri, hazırlanma süreçleri ve ilaç olarak kullanımları
PT941221E (pt) Dihidrobenzofuranos substituidos como inibidores de fosfodiesterase (pde)
WO2004007521A3 (en) Bile acid derivatives as agonists of the farnesoid x receptor
TR200200100T2 (tr) Kristalin 1-metilkarbapenem türevleri.
ATE345349T1 (de) Purinderivate
TR200001452T2 (tr) Bifenilamidin türevleri.
NO990914L (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
NO970806L (no) Dihydropyridin-derivater som bradykinin-antagonister
ZA976637B (en) The preparation of 3-pyrroline-2-carboxylic acid derivatives
NO20015202D0 (no) <beta>-hydroksyalkylamider, fremgangsmåte for deres fremstilling og deres anvendelse
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse